104UC201: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis |
|
|
| Active, not recruiting | N/A | 100 | RoW | baminercept (BG9924, LTβR-Ig) | Biogen Idec | Moderate to Severe Ulcerative Colitis | | | | |